PANK4 and pantothenate kinase-associated neurodegeneration: Recombinant PANK4 DUF89 domain-containing moiety has increased preference for oxidized P-PaSH and phosphatase activity toward P-Pa, which may reduce CoA synthesis in PKAN patients and result in unpleasant symptoms [37].